GlassScriptPhysician profile
Ryan K Sowle
NPI 1508365735
$4,254.22
in general payments reported to CMS, 2019-2025
23 companies · $714 in 2025
The $714 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,732 · 2022: $618 · 2023: $689 · 2024: $502 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,828.94 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Esprit |
| Novartis Pharmaceuticals Corporation | $454.77 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $287.22 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $282.02 | 2021-2025 | Watchman Flx, Watchman Access System, Accolade Sr |
| E.R. Squibb & Sons, L.L.C. | $174.64 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $162.43 | 2021-2024 | Symplicity G3, Euphora |
| Astrazeneca Pharmaceuticals LP | $151.93 | 2021-2025 | Brilinta, Farxiga, Wainua |
| Amgen INC. | $145.22 | 2021-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $139.24 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $110.08 | 2021-2024 | Verquvo |
| Philips North America LLC | $78.63 | 2022-2025 | Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.80 | 2021-2022 | |
| Pfizer INC. | $51.67 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $51.17 | 2025 | Evkeeza |
| Terumo Medical Corporation | $47.31 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $39.33 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $39.12 | 2023 | Inpefa |
| Shockwave Medical, INC | $34.77 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Celgene Corporation | $30.17 | 2022-2023 | Pomalyst |
| Inari Medical, INC. | $28.05 | 2022 | |
| W. L. Gore & Associates, INC. | $24.63 | 2022 | |
| Abiomed | $21.35 | 2025 | |
| Chiesi USA, INC. | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Sowle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.